A Randomized, Double-Blind, Comparative Therapy Evaluating Sitagliptin Versus Glibenclamide in Type 2 Diabetes Patients Already Treated with Pioglitazone and Metformin: A 3-Year Study

Diabetes Technology & Therapeutics , Vol. 0, No. 0.
Source: Diabetes Technology - Category: Endocrinology Tags: article Source Type: research